The Effect of Vitamin C on Atrial Fibrillation in Patients Underwent Coronary Artery Surgery; A Randomized Clinical Trial Study

Document Type : Original Article (s)

10.22122/jims.v39i614.13779

Abstract

Background: One of the most common cardiac arrhythmias after coronary artery bypass graft surgery is atrial fibrillation, and its occurrence is associated with an increase in the length of hospitalization morbidity and postoperative mortality. Recently, the role of oxidative stress in the pathophysiology of this arrhythmia has been raised. Current research was done to assess the role of prescribing vitamin C in preventing this arrhythmia.
Methods: In this clinical trial study, 140 patients who underwent coronary artery bypass graft surgery in Booali hospital, Qazvin, Iran, in the years 2016 to 2017 were randomly divided into two equal case and control groups. The case group received 1 g of vitamin C per day from 24 hours prior to 48 hours after surgery, and the control group received placebo at same time. Finally, data were analyzed using SPSS software, and incidence of postoperative atrial fibrillation was compared between the two groups.
Findings: Of 140 studied patients, 4 cases (5.7%) of the case group and 11 cases (15.71%) of control group had atrial fibrillation, and the difference between the two groups was significant (P = 0.028).
Conclusion: Our study showed that administration of oral vitamin C can effectively reduce the incidence of atrial fibrillation after coronary artery bypass graft surgery.

Keywords


Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY, et al. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace 2012; 14(11): 1553-9.
Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991; 84(5 Suppl): III236-III244.
Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: Analysis of 2588 patients. J Thorac Cardiovasc Surg 2004; 127(3): 779-86.
Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: A possible pathogenesis of atrial fibrillation. Med Hypotheses 2009; 72(4): 466-7.
Takenaka K, Ogawa E, Wada H, Hirata T. Systemic inflammatory response syndrome and surgical stress in thoracic surgery. J Crit Care 2006; 21(1): 48-53.
Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002; 97(1): 215-52.
Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: A systematic review. J Cardiothorac Surg 2010; 5: 121.
Chello M, Patti G, Candura D, Mastrobuoni S, Di Sciascio G, Agro F, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006; 34(3): 660-7.
Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337(25): 1785-91.
Moludi J, Keshavarz S, Mohammad Javad H, Rahimi Frooshani A, Sadeghpour A, Salarkia S, et al. Coenzyme Q10 effect in prevention of atrial fibrillation after Coronary Artery Bypass Graft: double-blind randomized clinical trial. Tehran Univ Med J 2015; 73(2): 79-85. [In Persian].
Mahan LK, Escott-Stump S. Krause's food, nutrition, and diet therapy. Philadelphia, PA: Saunders; 2004.
Sarzaeem M, Shayan N. Vitamin C in prevention of atrial fibrillation after coronary artery bypass graft: double blind randomized clinical trial. Tehran Univ Med J 2014; 71(12): 787-93. [In Persian].
Rasoli S, Kakouros N, Harling L, Gukop P, Soni M, Athanasiou T, et al. Antioxidant vitamins in the prevention of atrial fibrillation: What is the evidence? Cardiol Res Pract 2011; 2011: 164078.
Eslami M, Badkoubeh RS, Mousavi M, Radmehr H, Salehi M, Tavakoli N, et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 2007; 34(3): 268-74.
Banach M, Kourliouros A, Reinhart KM, Benussi S, Mikhailidis DP, Jahangiri M, et al. Postoperative atrial fibrillation - what do we really know? Curr Vasc Pharmacol 2010; 8(4): 553-72.
Rostagno C, La MM, Gelsomino S, Ghilli L, Rossi A, Carone E, et al. Atrial fibrillation after cardiac surgery: incidence, risk factors, and economic burden. J Cardiothorac Vasc Anesth 2010; 24(6): 952-8.
Moludi J, Keshavarz S, Pakzad R, Sedghi N, Sadeghi T, Alimoradi F. Effect of vitamin C supplementation in the prevention of atrial fibrillation. Tehran Univ Med J 2016; 73(11): 791-7. [In Persian].
Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O'Hara WW, Milfeld DJ. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg 2012; 204(6): 862-7.
Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001; 89(6): E32-E38.
Hemila H, Suonsyrja T. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017; 17(1): 49.
Ali-Hassan-Sayegh S, Mirhosseini SJ, Rezaeisadrabadi M, Dehghan HR, Sedaghat-Hamedani F, Kayvanpour E, et al. Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: An updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interact Cardiovasc Thorac Surg 2014; 18(5): 646-54.
Lewicki L, Siebert J, Rogowski J. Atrial fibrillation following off-pump versus on-pump coronary artery bypass grafting: Incidence and risk factors. Cardiol J 2016; 23(5): 518-23.